Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | transmembrane protease serine 3 | 0.00533414 | 0.0263164 | 0.37661 |
Onchocerca volvulus | 0.00533414 | 0.0263164 | 0.0263164 | |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0285291 | 0.6733 | 1 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.00533414 | 0.0263164 | 0.0390857 |
Loa Loa (eye worm) | hypothetical protein | 0.00533414 | 0.0263164 | 0.0390857 |
Onchocerca volvulus | 0.00533414 | 0.0263164 | 0.0263164 | |
Loa Loa (eye worm) | trypsin family protein | 0.00533414 | 0.0263164 | 0.0390857 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.00533414 | 0.0263164 | 0.0390857 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.00689584 | 0.0698771 | 0.5 |
Brugia malayi | Chymotrypsin-like protease CTRL-1 precursor | 0.00533414 | 0.0263164 | 0.0390857 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.00689584 | 0.0698771 | 0.103783 |
Leishmania major | hypothetical protein, conserved | 0.00689584 | 0.0698771 | 0.5 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.00533414 | 0.0263164 | 0.0390857 |
Schistosoma mansoni | aminopeptidase PILS (M01 family) | 0.00533414 | 0.0263164 | 0.0390857 |
Brugia malayi | Trypsin family protein | 0.0285291 | 0.6733 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0285291 | 0.6733 | 1 |
Brugia malayi | Trypsin family protein | 0.00533414 | 0.0263164 | 0.0390857 |
Onchocerca volvulus | 0.023195 | 0.524513 | 0.524513 | |
Schistosoma mansoni | hypothetical protein | 0.00689584 | 0.0698771 | 0.103783 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.00533414 | 0.0263164 | 0.0390857 |
Brugia malayi | Kringle domain containing protein | 0.00689584 | 0.0698771 | 0.103783 |
Loa Loa (eye worm) | hypothetical protein | 0.0285291 | 0.6733 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.00533414 | 0.0263164 | 0.0390857 |
Brugia malayi | hypothetical protein | 0.00533414 | 0.0263164 | 0.0390857 |
Giardia lamblia | High cysteine protein | 0.00439068 | 0 | 0.5 |
Loa Loa (eye worm) | variant SH3 domain-containing protein | 0.0111874 | 0.189582 | 0.281572 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.00689584 | 0.0698771 | 0.5 |
Brugia malayi | Trypsin-like protease protein 5 | 0.00533414 | 0.0263164 | 0.0390857 |
Toxoplasma gondii | PAN domain-containing protein | 0.0309062 | 0.739606 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.00533414 | 0.0263164 | 0.0390857 |
Echinococcus granulosus | transmembrane protease serine 3 | 0.00533414 | 0.0263164 | 0.37661 |
Onchocerca volvulus | 0.00533414 | 0.0263164 | 0.0263164 | |
Echinococcus multilocularis | subfamily S1A unassigned peptidase (S01 family) | 0.00533414 | 0.0263164 | 0.37661 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.00533414 | 0.0263164 | 0.0390857 |
Echinococcus multilocularis | Mastin | 0.00533414 | 0.0263164 | 0.37661 |
Loa Loa (eye worm) | hypothetical protein | 0.00689584 | 0.0698771 | 0.103783 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.00533414 | 0.0263164 | 0.0390857 |
Loa Loa (eye worm) | hypothetical protein | 0.00533414 | 0.0263164 | 0.0390857 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.00533414 | 0.0263164 | 0.0390857 |
Schistosoma mansoni | hypothetical protein | 0.00533414 | 0.0263164 | 0.0390857 |
Echinococcus multilocularis | glycoprotein Antigen 5 | 0.00533414 | 0.0263164 | 0.37661 |
Echinococcus granulosus | Peptidase S1 S6 chymotrypsin Hap | 0.00533414 | 0.0263164 | 0.37661 |
Schistosoma mansoni | hypothetical protein | 0.00533414 | 0.0263164 | 0.0390857 |
Brugia malayi | Variant SH3 domain containing protein | 0.0111874 | 0.189582 | 0.281572 |
Onchocerca volvulus | 0.0285291 | 0.6733 | 0.6733 | |
Echinococcus granulosus | Mastin | 0.00533414 | 0.0263164 | 0.37661 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.00689584 | 0.0698771 | 0.5 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.00533414 | 0.0263164 | 0.0390857 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.00533414 | 0.0263164 | 0.0390857 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.00533414 | 0.0263164 | 0.0390857 |
Echinococcus granulosus | glycoprotein Antigen 5 | 0.00533414 | 0.0263164 | 0.37661 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.00533414 | 0.0263164 | 0.0390857 |
Onchocerca volvulus | 0.0402416 | 1 | 1 | |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.00533414 | 0.0263164 | 0.0390857 |
Toxoplasma gondii | PAN domain-containing protein | 0.0309062 | 0.739606 | 1 |
Echinococcus granulosus | tissue type plasminogen activator | 0.00689584 | 0.0698771 | 1 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.00533414 | 0.0263164 | 0.0390857 |
Echinococcus multilocularis | enteropeptidase | 0.00533414 | 0.0263164 | 0.37661 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.00533414 | 0.0263164 | 0.0390857 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.00533414 | 0.0263164 | 0.0390857 |
Echinococcus granulosus | enteropeptidase | 0.00533414 | 0.0263164 | 0.37661 |
Brugia malayi | Trypsin family protein | 0.00533414 | 0.0263164 | 0.0390857 |
Echinococcus granulosus | subfamily S1A unassigned peptidase S01 family | 0.00533414 | 0.0263164 | 0.37661 |
Echinococcus multilocularis | Peptidase S1 S6, chymotrypsin Hap | 0.00533414 | 0.0263164 | 0.37661 |
Loa Loa (eye worm) | hypothetical protein | 0.00533414 | 0.0263164 | 0.0390857 |
Toxoplasma gondii | kringle domain-containing protein | 0.00689584 | 0.0698771 | 0.0944788 |
Brugia malayi | Protein kinase domain containing protein | 0.00689584 | 0.0698771 | 0.103783 |
Loa Loa (eye worm) | hypothetical protein | 0.0285291 | 0.6733 | 1 |
Brugia malayi | Trypsin family protein | 0.00533414 | 0.0263164 | 0.0390857 |
Onchocerca volvulus | 0.00533414 | 0.0263164 | 0.0263164 | |
Onchocerca volvulus | 0.00689584 | 0.0698771 | 0.0698771 | |
Loa Loa (eye worm) | hypothetical protein | 0.00533414 | 0.0263164 | 0.0390857 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.00689584 | 0.0698771 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.00533414 | 0.0263164 | 0.5 |
Onchocerca volvulus | 0.00533414 | 0.0263164 | 0.0263164 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AP (functional) | = 16.1 | Average potency of all four cell lines (P388 cell line, L1210 cell line, Molt 4/C8 cell line, CEM T-lymphocytes) | ChEMBL. | 11170648 |
CC50 (functional) | = 18 uM | Cytotoxicity against human HSC2 by MTT method | ChEMBL. | 17499885 |
CC50 (functional) | = 20 uM | Cytotoxicity against human HSC4 cells by MTT method | ChEMBL. | 17499885 |
CC50 (functional) | = 22 uM | Cytotoxicity against human HL60 cells in presence of RPMI1640 containing 10% fetal bovine serum by trypan blue exclusion test | ChEMBL. | 17499885 |
GI50 (functional) | -5.939 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.724 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.586 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.577 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.567 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.484 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.458 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.353 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.216 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.026 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.804 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | = 128 ng/ml | Antimalarial activity against drug-resistant Plasmodium falciparum C235 after 72 hrs by SYBR green I staining-based fluorescence assay | ChEMBL. | 24139941 |
IC50 (functional) | = 597 ng/ml | Antimalarial activity against liver stage Plasmodium berghei ANKA sporozoites infected in human HepG2 cells after 48 hrs by luciferase reporter gene assay | ChEMBL. | 24139941 |
IC50 (ADMET) | > 2000 ng/ml | Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay | ChEMBL. | 24139941 |
IC50 (functional) | = 0.74 uM | Cytotoxicity against murine P388 cells. | ChEMBL. | 11170648 |
IC50 (functional) | = 0.74 uM | Cytotoxicity against murine P388 cells. | ChEMBL. | 11170648 |
IC50 (functional) | = 7 uM | Cytotoxicity against Mus musculus (mouse) L1210 cells assessed as growth inhibition after 72 hr by MTT assay | ChEMBL. | No reference |
IC50 (functional) | = 8.63 uM | Cytotoxicity against CEM T-lymphocytes. | ChEMBL. | 11170648 |
IC50 (functional) | = 8.63 uM | Cytotoxicity against CEM T-lymphocytes. | ChEMBL. | 11170648 |
IC50 (functional) | = 13.4 uM | Cytotoxicity against human Molt 4/C8 cells. | ChEMBL. | 11170648 |
IC50 (functional) | = 41.5 uM | Cytotoxicity against murine L1210 cells. | ChEMBL. | 11170648 |
IC50 (functional) | = 41.5 uM | Cytotoxicity against murine L1210 cells. | ChEMBL. | 11170648 |
LogP | = 4.71 | Lipophilicity, log P of the compound | ChEMBL. | 18513966 |
Ratio (binding) | = 0.91 | Reversal of P-glycoprotein-mediated multidrug resistance in human MDR1 gene transfected mouse L5178Y cells assessed as fluorescence activity ratio at 40 ug/ml by flow cytometry | ChEMBL. | 18513966 |
Ratio (binding) | = 1.25 | Reversal of P-glycoprotein-mediated multidrug resistance in human MDR1 gene transfected mouse L5178Y cells assessed as fluorescence activity ratio at 4 ug/ml by flow cytometry | ChEMBL. | 18513966 |
Ratio (binding) | = 0.91 | Reversal of P-glycoprotein-mediated multidrug resistance in human MDR1 gene transfected mouse L5178Y cells assessed as fluorescence activity ratio at 40 ug/ml by flow cytometry | ChEMBL. | 18513966 |
Ratio (binding) | = 1.25 | Reversal of P-glycoprotein-mediated multidrug resistance in human MDR1 gene transfected mouse L5178Y cells assessed as fluorescence activity ratio at 4 ug/ml by flow cytometry | ChEMBL. | 18513966 |
Ratio IC50 (functional) | = 1.24 | Ratio of IC50 for drug-resistant Plasmodium falciparum C235 to IC50 for drug-sensitive Plasmodium falciparum D6 | ChEMBL. | 24139941 |
T1/2 (ADMET) | > 60 min | Half life in mouse plasma at 1 mM by LC/MS analysis | ChEMBL. | 24139941 |
T1/2 (ADMET) | > 60 min | Half life in human plasma at 1 mM by LC/MS analysis | ChEMBL. | 24139941 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Mus musculus | ChEMBL23 | 11170648 | |
Homo sapiens | ChEMBL23 | 11170648 | |
Plasmodium falciparum | ChEMBL23 | 24139941 | |
Plasmodium berghei | ChEMBL23 | 24139941 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.